sanofi-aventis' rimonabant delayed

sanofi-aventis (Euronext:SAN; SNY) said on Monday that FDA extended the PDUFA date for an NDA for rimonabant for

Read the full 187 word article

How to gain access

Continue reading with a
two-week free trial.